GlassScriptPhysician profile
James Brendan Wingo
NPI 1508835190
$2,859.31
in general payments reported to CMS, 2019-2025
30 companies · $1,169 in 2025
The $1,169 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $23.85 · 2022: $202 · 2023: $249 · 2024: $1,029 · 2025: $1,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,447.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $604.22 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $408.88 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $364.99 | 2020-2025 | |
| Amgen INC. | $239.70 | 2024-2025 | Otezla, Repatha, Repatha |
| Astellas Pharma US INC | $137.20 | 2025 | Veozah |
| Glaxosmithkline, LLC. | $120.52 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $111.92 | 2024-2025 | |
| Inari Medical, INC. | $104.10 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $91.91 | 2024 | |
| Exact Sciences Corporation | $88.21 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $83.20 | 2019-2025 | Airsupra |
| Janssen Pharmaceuticals, INC | $64.87 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $53.21 | 2025 | Caplyta |
| Insulet Corporation | $51.37 | 2024 | Omnipod |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.00 | 2024-2025 | Xifaxan, Trulance |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $36.27 | 2024 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $29.10 | 2022-2023 | |
| Axsome Therapeutics, INC. | $27.04 | 2025 | Auvelity |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.95 | 2024 | Siliq |
| Dexcom, INC. | $20.12 | 2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $19.23 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $18.41 | 2025 | |
| Inspire Medical Systems, INC. | $17.19 | 2025 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $17.11 | 2022 | |
| Biogen, INC. | $16.87 | 2025 | Skyclarys |
| Circassia INC. | $14.27 | 2019 | |
| Merck Sharp & Dohme LLC | $13.54 | 2023 | Verquvo, Belsomra |
| Irhythm Technologies, INC. | $13.07 | 2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.71 | 2019 | |
| Corium, LLC | $10.13 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wingo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.